IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IMUC was delisted on the 16th of October, 2018.

Back to rankings

16 hedge funds and large institutions have $221K invested in ImmunoCellular Therapeutics, Ltd. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$32K
2
+$12.6K
3
+$12K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$6.68K

Top Sellers

1
-$445K
2
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$112K
2
$55K
3
$32K
4
$12K
5
$9K
6
$1K
7
–
8
–